Markets.com Logo

SANA

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    3.4393$
  • Previous Close
    3.6017$
  • 52 Week Change
    5.08$
  • Day Range
    -0.16$
  • 52 Week High/Low
    1.26$ - 6.34$
  • Dividend Per Share
    --
  • Market cap
    881 M$
  • EPS
    -0.39
  • Beta
    1.906
  • Volume
    --

About

Sana Biotechnology, Inc. (SANA.US) is a biotechnology company focused on engineering cells as medicines to treat and potentially cure diseases. Their approach involves both in vivo and ex vivo cell engineering, with a focus on areas like oncology, immunology, and genetic diseases. Sana Biotechnology is still in the clinical trial phase, with a pipeline of preclinical and clinical programs aimed at developing transformative therapies. As such, investing in SANA.US carries the risks associated with early-stage biotechnology companies, including uncertainty surrounding regulatory approval and commercial viability.

Fed's New Era: Warsh Signals Caution Amid Inflation and Market Jitters

Emma Rose|--

Storage Chip Sector Rebound: Is AI Sustaining the Cycle?

Sophia Claire|--

New Fed Chair Kevin Warsh: Reshaping Communication and Steering Market Expectations

Emma Rose|--

Goldman Sachs Revises 2027 Brent Crude Forecast to $80/bbl Amid Shifting Supply and Demand Dynamics

Sophia Claire|--

US Stock Market Volatility Surges as Trading Logic Breaks Down

Emma Rose|--

2026 World Cup: A Watershed Moment for Predictive Markets and a Boost for DraftKings

Emma Rose|--

Japanese Tungsten Hexafluoride Production Halt Disrupts Global Semiconductor Supply Chain

Sophia Claire|--

Factors

[Company Performance]: SANA's revenue, earnings, and growth prospects influence investor confidence and stock valuation. Positive financial reports typically drive the stock price up.

[Industry Trends]: Overall trends within the biotechnology sector, including advancements in cell therapy and regulatory changes, can impact investor sentiment towards SANA.

[Market Sentiment]: General market conditions and investor risk appetite can affect the demand for SANA shares. Bull markets often lead to higher valuations, while bear markets can depress prices.

[Regulatory Approvals]: The success or failure of SANA's therapies in clinical trials and the likelihood of regulatory approvals significantly impact the stock price. Positive trial data typically leads to increases.

[Competition]: The competitive landscape, including the presence of competing therapies and companies, affects SANA's market share and growth potential, thereby impacting its stock price.

[Macroeconomic Factors]: Economic indicators such as interest rates, inflation, and GDP growth can indirectly influence investor sentiment and the valuation of growth stocks like SANA.

People Also Watch

Latest news

Qatar's Delicate Energy Diplomacy Amidst Regional Conflict: A Balancing Act

Sophia Claire|--

Lebanon: A Geopolitical Chessboard of Iranian Influence and US Diplomacy

Emma Rose|--

Global Market Snapshot: Key Events and Analysis of Financial Markets

Liam James|--

Latest Education Articles

Most Volatile Forex Pairs: What Traders Should Know

Most Volatile Forex Pairs: What Traders Should Know

Julian Parker|--
What Happens on the Day of an IPO?

What Happens on the Day of an IPO?

Julian Parker|--
10 Hot IPO Stocks to Watch in 2026: SpaceX, Anthropic, OpenAI and More

10 Hot IPO Stocks to Watch in 2026: SpaceX, Anthropic, OpenAI and More

Julian Parker|--
Recommended Topics